• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Profound Medical Corp. - common stock (NQ:PROF)

    7.070 +0.520 (+7.94%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Aug 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 248,013
    Open 6.870
    Bid (Size) 7.050 (100)
    Ask (Size) 7.080 (1,200)
    Prev. Close 6.550
    Today's Range 6.780 - 7.160
    52wk Range 3.760 - 8.950
    Shares Outstanding 20,208,948
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
    Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day 
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Announces Management Change
    From Profound Medical Corp.
    Via GlobeNewswire

    Performance

    YTD
    -7.7%
    -7.7%
    1 Month
    +3.8%
    +3.8%
    3 Month
    +2.6%
    +2.6%
    6 Month
    +5.8%
    +5.8%
    1 Year
    +48.8%
    +48.8%

    More News

    Read More
    News headline image
    Profound Medical (PROF) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Profound Medical Reports Second Quarter 2026 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
    From Telix Pharmaceuticals Limited
    Via GlobeNewswire
    News headline image
    Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Profound Medical Reports Strong First Quarter 2026 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
    From Profound Medical Corp.
    Via GlobeNewswire
    Here are the top movers in Friday's session. ↗
    Via Chartmill
    News headline image
    Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
    From Profound Medical Corp.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Profound Medical Corp. - common stock publicly traded?
    Yes, Profound Medical Corp. - common stock is publicly traded.
    What exchange does Profound Medical Corp. - common stock trade on?
    Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Profound Medical Corp. - common stock?
    The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
    What is the current price of Profound Medical Corp. - common stock?
    The current price of Profound Medical Corp. - common stock is 7.070
    When was Profound Medical Corp. - common stock last traded?
    The last trade of Profound Medical Corp. - common stock was at 08/18/26 03:59 PM ET
    What is the market capitalization of Profound Medical Corp. - common stock?
    The market capitalization of Profound Medical Corp. - common stock is 142.88M
    How many shares of Profound Medical Corp. - common stock are outstanding?
    Profound Medical Corp. - common stock has 143M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.